> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Expedited Programs for Drugs/Biologics Info Collection
- URL: https://www.fdaweb.com/expedited-programs-for-drugs-biologics-info-collection/
- Published: 2021-02-18T12:00:00.000Z
- Updated: 2026-09-14T16:47:29.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148695

*Federal Register* notice: FDA has submitted to OMB an information collection extension for “Expedited Programs for Serious Conditions — Drugs and Biologics” (OMB Control Number 0910-0765). The collection supports agency regulations and associated guidance that establish procedures designed to expedite the development, evaluation, and marketing of new therapies intended to treat persons with life-threatening and severely debilitating illnesses, especially where no satisfactory alternative therapy exists. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-02-18/pdf/2021-03244.pdf?ref=fdaweb.com).